We are live on ! Find out more
CHRS icon

Coherus Oncology
CHRS

78 hedge funds and large institutions have $322M invested in Coherus Oncology in 2015 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 29 increasing their positions, 22 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 22

21% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 14

4% more funds holding

Funds holding: 75 → 78 (+3)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

26% less capital invested

Capital invested by funds: $434M → $322M (-$112M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1.47M

Holders
78
Holders Change
+3
Holders Change %
+4%
% of All Funds
2.18%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
17
Increased
29
Reduced
22
Closed
14
Calls
–
Puts
$1.47M
Net Calls
-$1.47M
Net Calls Change
-$1.39M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$31.8M
2
NI
Numeric Investors
Massachusetts
+$6.15M
3
Fidelity International
Fidelity International
Bermuda
+$4.87M
4
BIT
BlackRock Institutional Trust
California
+$4.86M
5
CGI
CI Global Investments
California
+$4.56M

Top Sellers

Rank Fund Capital Flow
1
RSCM
Rock Springs Capital Management
Maryland
-$7.58M
2
PA
Perceptive Advisors
New York
-$7.48M
3
JP Morgan Chase
JP Morgan Chase
New York
-$4.56M
4
Millennium Management
Millennium Management
New York
-$3.84M
5
RFC
Russell Frank Company
Washington
-$3.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
Hudson Bay Capital Management
26
Hudson Bay Capital Management
Connecticut
$2.91M +$4.42M +145,261 New
SFM
27
Soros Fund Management
New York
$2.56M – – –
CWG
28
C WorldWide Group
Denmark
$2.48M +$1.95M +64,000 +107%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$1.79M +$87.4K +2,871 +3%
Renaissance Technologies
30
Renaissance Technologies
New York
$1.71M +$1.36M +44,593 +109%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$1.69M -$317K -10,427 -11%
BIM
32
BlackRock Investment Management
Delaware
$1.65M -$32.5K -1,067 -1%
Charles Schwab
33
Charles Schwab
California
$988K +$69.3K +2,276 +5%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$861K -$3.04K -100 -0.2%
TI
35
Trexquant Investment
Connecticut
$769K +$1.17M +38,400 New
EI
36
EAM Investors
California
$715K +$1.08M +35,656 New
TA
37
Teachers Advisors
New York
$688K – – –
AllianceBernstein
38
AllianceBernstein
Tennessee
$684K +$25K +820 +2%
PCM
39
Pyrrho Capital Management
New York
$544K +$826K +27,133 New
Franklin Resources
40
Franklin Resources
California
$501K +$761K +25,000 New
Deutsche Bank
41
Deutsche Bank
Germany
$471K -$34.9K -1,146 -5%
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$465K +$175K +5,765 +33%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$416K +$26.3K +864 +4%
Swiss National Bank
44
Swiss National Bank
Switzerland
$359K +$295K +9,700 +118%
BCM
45
Bourgeon Capital Management
Connecticut
$351K +$228K +7,500 +75%
MLICM
46
Metropolitan Life Insurance Company (MetLife)
New York
$337K +$512K +16,813 New
SAM
47
Sectoral Asset Management
Quebec, Canada
$331K +$15.9K +524 +3%
Morgan Stanley
48
Morgan Stanley
New York
$310K +$181K +5,952 +62%
NFA
49
Nationwide Fund Advisors
Ohio
$305K – – –
AIG
50
American International Group
New York
$277K +$487 +16 +0.1%
1
2
3 4

CHRS Hedge Fund Activity: Q3 2015 in Review

78 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q3 2015, worth a combined $322M — down 26% from $434M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new CHRS positions and 14 closed out — a net gain of 3 holders — while 29 added to existing stakes and 22 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $31.8M. The largest seller was Rock Springs Capital Management, cutting an estimated $7.58M.

  • 78 institutional investors held Coherus Oncology (CHRS) as of Q3 2015, up from 75 in Q2 2015.
  • Funds reported $322M of Coherus Oncology stock for Q3 2015, down 26% quarter-over-quarter.
  • 17 funds opened new Coherus Oncology positions in Q3 2015 and 14 closed out, a net change of +3 holders.
  • The largest Coherus Oncology buyer in Q3 2015 was Fidelity Investments, an estimated $31.8M added.
  • The largest Coherus Oncology seller in Q3 2015 was Rock Springs Capital Management, an estimated $7.58M sold.

Based on aggregated 13F filings for Q3 2015.